Lotus Pharm vs Mycenax Biotech: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Mycenax Biotech (4726) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Mycenax Biotech

0%+393%-49%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYMycenax BiotechYoY
Oct 2026NT$2.13 billion-22.5%NT$98 million+41.0%
Sep 2026NT$2.77 billion+128.0%NT$116.4 million+393.3%
Aug 2026NT$2.11 billion+81.7%NT$105.9 million+131.4%
Jul 2026NT$2.49 billion+3.9%NT$86 million+38.6%
Jun 2026NT$3.4 billion+225.5%NT$53.8 million-48.9%
May 2026NT$2.32 billion+105.8%NT$42.5 million-39.7%
Apr 2026NT$3.09 billion+19.9%NT$106.7 million+301.0%
Mar 2026NT$4.35 billion+173.6%NT$94.6 million+78.6%
Feb 2026NT$2.24 billion+131.5%NT$56.6 million+140.4%
Jan 2026NT$2.05 billion-5.5%NT$45.7 million+0.9%
Dec 2025NT$2.44 billion+66.9%NT$127.3 million+156.4%
Nov 2025NT$1.06 billion-0.2%NT$87.8 million-19.5%
Oct 2025NT$2.75 billion+46.0%NT$69.5 million+97.1%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16